Alpha Tau Medical Ltd. Profile

Industry
Biotechnology
Sector
Healthcare
Number of Employees
121

Alpha Tau Medical Ltd.'s Business Model

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

About Alpha Tau Medical Ltd.

Website: https://www.alphatau.com

CEO (Chief Executive Officer): Mr. Uzi Sofer

IPO date: 2021-03-08

Contact

Country: IL

Address: 5 Kiryat Hamada Street

City: Jerusalem

State: None

Phone: 972 3 577 4115

Zip Code: 9777605

Other

CIK: 0001871321

ISIN: IL0011839383

CUSIP: M0740A108

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.